Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1478437/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832583626704814080 |
|---|---|
| author | Ting Li Ting Fang Linxin Xu Xiangyang Liu Xiaoyu Li Mei Xue Xiaochen Yu Bei Sun Liming Chen |
| author_facet | Ting Li Ting Fang Linxin Xu Xiangyang Liu Xiaoyu Li Mei Xue Xiaochen Yu Bei Sun Liming Chen |
| author_sort | Ting Li |
| collection | DOAJ |
| format | Article |
| id | doaj-art-e88372f9a8214d199e8dbbc3e4a4730a |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-e88372f9a8214d199e8dbbc3e4a4730a2025-01-28T10:35:46ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011610.3389/fphar.2025.14784371478437Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitroTing LiTing FangLinxin XuXiangyang LiuXiaoyu LiMei XueXiaochen YuBei SunLiming Chenhttps://www.frontiersin.org/articles/10.3389/fphar.2025.1478437/fullempagliflozinautophagydiabetesmetabolic associated fatty liver diseaselipid accumulationten-eleven translocation 2 |
| spellingShingle | Ting Li Ting Fang Linxin Xu Xiangyang Liu Xiaoyu Li Mei Xue Xiaochen Yu Bei Sun Liming Chen Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro Frontiers in Pharmacology empagliflozin autophagy diabetes metabolic associated fatty liver disease lipid accumulation ten-eleven translocation 2 |
| title | Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro |
| title_full | Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro |
| title_fullStr | Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro |
| title_full_unstemmed | Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro |
| title_short | Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro |
| title_sort | corrigendum empagliflozin alleviates hepatic steatosis by activating the ampk tet2 autophagy pathway in vivo and in vitro |
| topic | empagliflozin autophagy diabetes metabolic associated fatty liver disease lipid accumulation ten-eleven translocation 2 |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1478437/full |
| work_keys_str_mv | AT tingli corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro AT tingfang corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro AT linxinxu corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro AT xiangyangliu corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro AT xiaoyuli corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro AT meixue corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro AT xiaochenyu corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro AT beisun corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro AT limingchen corrigendumempagliflozinalleviateshepaticsteatosisbyactivatingtheampktet2autophagypathwayinvivoandinvitro |